Sarepta Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Sarepta Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD" ALT"Sarepta Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD"February 10, 2017By Mark Terry,…

Continue ReadingSarepta Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD

Aurobindo Eyes U.S. Plant in New Jersey As Calls for Local Drug Production

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-aurobindo.jpg" NAME"Aurobindo Eyes U.S. Plant in New Jersey As Trump Calls for Local Drug Production" ALT"Aurobindo Eyes U.S. Plant in New Jersey As Trump Calls for Local Drug Production"February…

Continue ReadingAurobindo Eyes U.S. Plant in New Jersey As Calls for Local Drug Production

3 Biotech Stocks Able to Weather an Unstable Administration

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"3 Biotech Stocks Able to Weather an Unstable Trump Administration" ALT"3 Biotech Stocks Able to Weather an Unstable Trump Administration"February 10, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue Reading3 Biotech Stocks Able to Weather an Unstable Administration

Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why Intercept Stock Jumped Nearly 10% On Friday After Providing Phase III Update" ALT"Why Intercept Stock Jumped Nearly 10% On Friday After Providing Phase III Update"February 10, 2017By…

Continue ReadingWhy Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update